Plus Therapeutics regains compliance with applicable Nasdaq listing criteria

1 hour ago 1

Plus Therapeutics (NASDAQ:PSTV) on Tuesday said it has received a letter from Nasdaq, confirming its compliance.
Specifically, the letter confirms that the company is in compliance with both the Market Value of Listing Securities standard, which requires certain companies to maintain a